Pharmahof Glizide

Pharmahof Glizide

glipizide

Manufacturer:

Pharmahof

Distributor:

Pharmahof
Concise Prescribing Info
Contents
Glipizide
Indications/Uses
Maturity-onset diabetes not manageable by diet alone.
Dosage/Direction for Use
Initially ½ to 1 tab daily. Max dose: 8 tab daily in 2 divided doses.
Administration
Should be taken on an empty stomach: Take 30 min before meals.
Contraindications
Hypersensitivity. Type II DM w/ ketoacidosis & type 1 DM.
Special Precautions
Increased risk of hypoglycemia. Renal or hepatic impairment. Not recommended during pregnancy & lactation.
Adverse Reactions
GI disturbances eg, nausea, vomiting, heart burn, anorexia, diarrhoea; skin rashes, pruritus, photosensitivity, hypoglycemic coma, cholestatic jaundice, leucopenia, thrombocytopenia, agranulocytosis & hemolytic anemia.
Drug Interactions
Increased hypoglycemic effect w/ anabolic steroids; ACE inhibitors; H2 antagonists, antacids, oral Na bicarbonate. Increased levels/effects w/ CYP2C8/9 inhibitors eg, delavirdine, fluconazole, gemfibrozil, ketoconazole, nicardipine, NSAIDs, pioglitazone, sulfonamides. Increased serum conc w/ cyclosporine; tacrolimus. Decreased hypoglycemic effect w/ β-blockers; ethanol; rifampin. Decreased absorption w/ cholestyramine. Decreased levels/effects w/ CYP2C8/9 inducers eg, carbamazepine, phenobarb, phenytoin, rifampin, rifapentine, secobarbital. Hyperglycemia w/ corticosteroids.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB07 - glipizide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glizide tab 5 mg
Packing/Price
100 × 15's;5 × 15's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in